AbCellera to release phase 2 trial data for menopause drug Aug. 10

August 7, 2026 4:30 PM

AbCellera Biologics (Nasdaq: ABCL) said it will release top-line data from its Phase 2 trial of ABCL635, an antibody drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found